These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 20166336)
1. Lessons learned from 2 years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center. Gur AY; Shopin L; Bornstein NM Isr Med Assoc J; 2009 Dec; 11(12):714-6, 718. PubMed ID: 20166336 [TBL] [Abstract][Full Text] [Related]
2. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related]
3. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397 [TBL] [Abstract][Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
5. Trombolysis in acute stroke. Schwammenthal Y; Tsabari R; Bakon M; Orion D; Merzeliak O; Tanne D Isr Med Assoc J; 2006 Nov; 8(11):784-7. PubMed ID: 17180831 [TBL] [Abstract][Full Text] [Related]
6. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959 [TBL] [Abstract][Full Text] [Related]
7. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
8. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
9. [Thrombolytic therapy in cerebral infarction]. Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies. Külkens S; Hacke W Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385 [TBL] [Abstract][Full Text] [Related]
11. Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study. Jovanović DR; Beslać-Bumbasirević Lj; Budimkić M; Pekmezović T; Zivković M; Kostić VS; Clin Neurol Neurosurg; 2009 Nov; 111(9):729-32. PubMed ID: 19647928 [TBL] [Abstract][Full Text] [Related]
12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405 [TBL] [Abstract][Full Text] [Related]
13. [Effective acute stroke treatment beyond approval limitations: intravenous thrombolysis within an extended time window (3-6 h) and in old patients (aged 80 or older)]. Thomalla G; Köhrmann M; Röther J; Schellinger PD Fortschr Neurol Psychiatr; 2007 Jun; 75(6):343-50. PubMed ID: 17366377 [TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group. Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752 [TBL] [Abstract][Full Text] [Related]
15. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Abdullah AR; Smith EE; Biddinger PD; Kalenderian D; Schwamm LH Prehosp Emerg Care; 2008; 12(4):426-31. PubMed ID: 18924004 [TBL] [Abstract][Full Text] [Related]
16. Acute stroke management in the elderly. Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089 [TBL] [Abstract][Full Text] [Related]
17. Thromobolysis for acute ischemic stroke: is intra-arterial better than intravenous? A treatment effects model. Powers WJ J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):401-3. PubMed ID: 22464277 [TBL] [Abstract][Full Text] [Related]
18. De-novo thrombolysis for recurrent stroke in a patient with prior history of thrombolysis. Arsava EM; Topcuoglu MA Blood Coagul Fibrinolysis; 2010 Sep; 21(6):605-7. PubMed ID: 20644467 [TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis in acute ischemic stroke due to occlusion of internal carotid artery - a Serbian Experience with Thrombolysis in Ischemic Stroke (SETIS). Zivanovic Z; Gvozdenovic S; Jovanovic DR; Lucic-Prokin A; Sekaric J; Lukic S; Kokai-Zekic T; Zarkov M; Cvijanovic M; Beslac-Bumbasirevic L; Slankamenac P; Clin Neurol Neurosurg; 2014 May; 120():124-8. PubMed ID: 24731591 [TBL] [Abstract][Full Text] [Related]
20. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. Katzan IL; Furlan AJ; Lloyd LE; Frank JI; Harper DL; Hinchey JA; Hammel JP; Qu A; Sila CA JAMA; 2000 Mar; 283(9):1151-8. PubMed ID: 10703777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]